1. Introduction {#sec1-marinedrugs-17-00164}
===============

As per a WHO report, about 17 million individuals are supposed to die due to cardiovascular infections. The frequency of the intense myocardial localized necrosis is increasing around the world \[[@B1-marinedrugs-17-00164]\]. Thrombus develops inside arteries, leading to thrombosis, heart stroke, and pulmonary embolism \[[@B2-marinedrugs-17-00164]\]. Therefore, thrombolytic treatments have become a traditional remedy regarding acute myocardial infarction (AMI). Synthetic therapeutics used in such disorders has serious adverse effects, so there is a need to investigate new and safe natural thrombolytic agents \[[@B3-marinedrugs-17-00164]\]. Protein treatments are turning out to be more pervasive in present day solutions for AMI. Since a wide source is available, microbial fibrinolytic enzymes have attracted a great deal of therapeutic enthusiasm during the last decade \[[@B4-marinedrugs-17-00164]\]. For every fibrinolytic protease, there is a unique spotlight on the protein structure and activity. Proteases guarantee no side-effects to patients with inborn shortcomings. Hence, drug screening programs focused on microbial enzymes are found to be better alternatives. The discoveries of new members of actinomycetes and novel metabolites from marine environments have drawn attention towards marine sponges and sediments \[[@B5-marinedrugs-17-00164]\]. It has been reported that marine actinomycetes are extensive sources of metabolites with anti-viral, anti-bacterial, anti-tumor, anti-helminthic, insecticidal, immune-modulatory, and immunosuppressant properties when compared to terrestrial actinomycetes \[[@B6-marinedrugs-17-00164]\]. Marine actinomycetes were mostly isolated from sand, water, rock, and mangrove sediments. The colonies have aerial mycelium powdery appearance distinguished from bacteria; they are gram positive and filamentous in nature \[[@B7-marinedrugs-17-00164]\]. Actinokinase (AK) enzyme isolated from *Streptomyces megasporous* SD5 has shown thrombolytic activity similar to that of urokinase from human urine, which is fibrin specific. This extracellular protein is composed of 242 amino acids with a molecular weight of 35 kDa \[[@B8-marinedrugs-17-00164]\]. Fibrinolytic protease producing *Streptomyces violaceus* VITYGM from marine soil samples \[[@B9-marinedrugs-17-00164]\] and *Streptomyces venezuela* from marine water samples \[[@B10-marinedrugs-17-00164]\] were also reported previously. The expanding capability of AK applications elevated us to screen for novel and AK delivering from marine creatures. This offers extensive points of interest over the other reported marine *Streptomyces* sp. in view to the significance of the marine system which provides a rich source of novel actinomycetes and the increased industrial applications of the enzymes. Hence the present study aims to study the novel fibrinolytic enzyme producing actinomycetes isolated from marine sponges. To the best of our knowledge, this is the first report given on *Streptomyces* sp. from marine brown tube sponge *Agelas conifera* for a new potential fibrinolytic actinokinase.

2. Materials and Methods {#sec2-marinedrugs-17-00164}
========================

2.1. Chemicals {#sec2dot1-marinedrugs-17-00164}
--------------

Bovine serum albumin, tyrosine, thrombin, and standard streptokinase were obtained from Sigma Aldrich (Bengaluru, India). Starch casein agar, ISP broth, glucose, yeast extract, ammonium sulfate, manganese chloride, sodium carbonate, sodium bicarbonate, magnesium sulfate, sodium acetate, sodium chloride, sodium hydroxide, and ferrous sulfate were purchased from Hi Media laboratories (Mumbai, India). Copper sulfate, Folin--Ciocalteau reagent, potassium dihydrogen phosphate, trichloroacetic acid (TCA), hydrochloric acid (HCl), ethylene-diaminetetraacetic acid (EDTA), and Tris-HCl were purchased from Sisco research laboratories (SRL, Mumbai, India).

2.2. Sample Collection and Isolation of Actinomycetes {#sec2dot2-marinedrugs-17-00164}
-----------------------------------------------------

### 2.2.1. Collection of Sponges {#sec2dot2dot1-marinedrugs-17-00164}

Three varieties of sponges were collected from the Rameshwaram Sea coast positioned on the eastern coast line, 28 km from Ramanathapuram with 9°281′ latitude and 79°301′ longitude. Sponges were collected in sterile polythene bags. The sponges were distinguished by their morphological appearance \[[@B11-marinedrugs-17-00164]\]. Following collection, many epiphytic faunas were removed with sterile marine water in order to remove microbes originating from ecological marine normal water.

### 2.2.2. Spicule Preparation {#sec2dot2dot2-marinedrugs-17-00164}

For spicule preparation, the sponge fragments were taken in a test tube and 10 volumes of fuming nitric acid (HNO~3~) were added and kept for steaming, till the cell product was smeared \[[@B12-marinedrugs-17-00164],[@B13-marinedrugs-17-00164]\].

### 2.2.3. Isolation and Screening for *Streptomyces* sp. from Marine Sponges {#sec2dot2dot3-marinedrugs-17-00164}

Sponges were portioned into smaller items by using sterile and clean scissors. They were smashed with a sterile mortar and pestle. Serially diluted around 10^−6^ and inoculated in Starch casein agar plate. The fibrinolytic activity of *Streptomyces* sp. was screened by casein plate assay.

2.3. Bacterial Strain and Culture Conditions {#sec2dot3-marinedrugs-17-00164}
--------------------------------------------

*Streptomyces* sp. was cultured in a medium containing (g/L): starch, 10; K~2~HPO~4~, 2; KNO~3~, 2; NaCl, 2; Casein, 0.3, and remaining trace amount salts were MgSO~4~, CaCO~3~, and FeSO~4~. Cultivation was carried out for 48 h on a rotatory shaker set at 33 °C and 140 rpm \[[@B14-marinedrugs-17-00164]\].

2.4. Determination of Protease Activity by Caseinolytic Method {#sec2dot4-marinedrugs-17-00164}
--------------------------------------------------------------

Protease activities of the isolates were determined by standard caseinolytic assay \[[@B15-marinedrugs-17-00164]\].

2.5. Quantification of Protein and Enzyme Activity {#sec2dot5-marinedrugs-17-00164}
--------------------------------------------------

Protein content was determined by Lowry's method \[[@B16-marinedrugs-17-00164]\] using bovine serum albumin as the standard protein. Protease activity was determined by Folin--Ciocalteu method using tyrosine as the standard \[[@B17-marinedrugs-17-00164]\].

2.6. Characterization of Selected Streptomyces sp. {#sec2dot6-marinedrugs-17-00164}
--------------------------------------------------

The selected strains were characterized according to the method employed by collaborators in the International *Streptomyces* Project \[[@B18-marinedrugs-17-00164]\].

### 2.6.1. Molecular and Phylogenetic Analysis {#sec2dot6dot1-marinedrugs-17-00164}

Total genomic DNA was isolated using the phenol chloroform method \[[@B19-marinedrugs-17-00164]\]. PCR amplification of 16S rDNA was done. The PCR product was detected by agarose gel electrophoresis. The sequence was subjected to a homology search using the BLAST program of the National Center for Biotechnology Information (NCBI). The acquired sequences were used for a gene homology search, with the 16S rDNA sequences available in the public databases from BLAST and identified to the generic level. The 16S rDNA sequences aligned from the Gen Bank database and a phylogenetic tree was constructed via the EvolView program \[[@B20-marinedrugs-17-00164]\].

### 2.6.2. Scanning Electron Microscope (SEM) Analysis {#sec2dot6dot2-marinedrugs-17-00164}

*Streptomyces* sp. from the plate was streaked onto inclined coverslips \[[@B21-marinedrugs-17-00164]\]. These coverslips were subjected to a vacuum evaporator provided with a variable tilt, rotary specimen support. The metal-plated coverslips were examined with a Scanning Electron microscope Model "Zeiss EVO 18", Oberkochen, Germany.

2.7. Optimization {#sec2dot7-marinedrugs-17-00164}
-----------------

A total of four different carbon sources, maltose, dextrose, oat meal, and starch, were used, the nitrogen sources casein, yeast extract, peptone, and L-aspargine were used for optimization. The optimum temperature and pH were 33 °C and 7.2 respectively. The temperature and pH were kept constant for carbon-nitrogen source optimization. The effects of pH and temperature were determined by the Folin--Ciocalteu method. The effect of pH varied from (3--11) using standard buffers: citric acid--sodium phosphate (pH 3--7), Tris--HCl (pH 7.5--9), and NaHCO~3~ (pH 9.6--11). To determine the pH stability of the enzyme, aliquots of enzyme samples were incubated with the respective buffers for 3 h at 18 °C, and the residual activities were measured at pH 7.2. The temperature optimum of *Streptomyces radiopugnans* VITSD8 was assessed by carrying out the enzyme assay at various temperatures (4--60 °C) at pH 7.2.

2.8. Purification {#sec2dot8-marinedrugs-17-00164}
-----------------

*Streptomyces radiopugnans* VITSD8 was cultured for 48 h, centrifuged at 10,000 rpm for 1 h and solid (NH~4~)~2~SO~4~ at 0--85% saturation was added to the supernatant to precipitate the proteins. Proteins were recovered by centrifugation at 8000 rpm for 15 min at 4 °C, dialyzed against 10 mM Tris--HCl buffer (pH 7.2) and concentrated with an ultra-filtration membrane (Millex syringe filter Darmstadt, Germany). The enzyme was then subjected to gel filtration on a Sepharose CL-6B column (120 cm 2.2 cm), pre-equilibrated with 10 mM Tris--HCl buffer (pH 7.2) at a flow rate of 15 mL/h. The active fractions with high specific activities were pooled, concentrated, and further purified using a Poros-HQ ion exchange column (10 cm × 1 cm), pre-equilibrated with 10 mM Tris--HCl buffer (pH 7.2). The bound proteins were eluted with a gradient of 10 mM Tris--HCl buffer (pH 7.2) containing 0--1 M HCl at a flow rate of 30 mL/h \[[@B22-marinedrugs-17-00164]\]. The molecular weight of the obtained enzyme was determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) \[[@B23-marinedrugs-17-00164]\]. The protein standard albumin (66.2 kDa), ovalbumin (45 kDa), and carbonic anhydrase (29 kDa) were used as markers.

2.9. Blood Clot Lysis Assay {#sec2dot9-marinedrugs-17-00164}
---------------------------

Clot lysis activity of the enzyme was determined by modified Holmstrom method \[[@B24-marinedrugs-17-00164]\].

2.10. Fibrin Plate Method {#sec2dot10-marinedrugs-17-00164}
-------------------------

The fibrin plate method was used to determine the activity of purified *Streptomyces* protease against the clot \[[@B25-marinedrugs-17-00164]\].

2.11. Partial Clot Lysis Assay {#sec2dot11-marinedrugs-17-00164}
------------------------------

Clot lysis activity of the purified enzyme was determined by the percentage of red blood cells (RBCs) released at 275 nm. The percentage of total clot lysis was calculated with reference to the calibrated curve of RBCs used in the clot, in which the 100% was equivalent to all the RBCs in the clot being released into the surrounding fluid \[[@B2-marinedrugs-17-00164]\].

2.12. HPLC Analysis {#sec2dot12-marinedrugs-17-00164}
-------------------

The fractions obtained were analyzed for protein purity by HPLC using a C18 column, UV Detector-2487 (Waters HPLCPump-1525, Milford, MA, USA). The mobile phase acetonitrile and water were in the ratio of 1:1, and purity was validated at 280 nm.

2.13. FTIR Analysis {#sec2dot13-marinedrugs-17-00164}
-------------------

FTIR spectra of samples were measured using FTIR spectrometer (IR Affinity-1Shimadzu, Kyoto, Japan). Approximately 0.5 mg of the sample was mixed with 1% of potassium bromide and compressed to get a pellet and analyzed \[[@B26-marinedrugs-17-00164]\].

3. Results and Discussion {#sec3-marinedrugs-17-00164}
=========================

In the present study, a total of three species of sponge were collected from Rameshwaram, Tamil Nadu, India. The species of the sponges were identified by their characteristic morphological appearance and structural spicule appearance on observing spicules prepared with 10% formalin. All the three marine sponges were identified, as *Niphates erecta* (Niphates), *Desmapsamma anchorata* (Desmacididae), and *Agelas conifera* (Agelasidae) \[[@B27-marinedrugs-17-00164]\]. *Niphates erecta* (Niphates), commonly known as lavender rope sponge, has a characteristic appearance of greyish brown color with irregular distribution of oscules ([Figure 1](#marinedrugs-17-00164-f001){ref-type="fig"}A), *Desmapsamma anchorata* is soft and slimy sponge lumpy growing sponge with volcano-shaped oscules on the elevations (Desmacididae) ([Figure 1](#marinedrugs-17-00164-f001){ref-type="fig"}B), and *Agelas confiera* (Agelasidae) is a brown tube sponge with a characteristic stiff consistency, aerial hyphae morphology grey color ([Figure 1](#marinedrugs-17-00164-f001){ref-type="fig"}C) \[[@B11-marinedrugs-17-00164]\]. They are classified according to the specific spicule of each species and they have monoaxonic and tetra axonic silicious spicules \[[@B27-marinedrugs-17-00164]\]. They are structurally colored. The strain VITSD8 was isolated from the sponge *Agelas confiera*, and had monoaxonic and tetra axonic silicious spicules. The isolation of *Streptomyces* sp. was carried out using starch casein agar. A total of 68 colonies were isolated from three species of marine sponges. Only 16 strains were selected based on their mycelium color. The isolated colonies had a powdery appearance with a characteristic feature of a warty surface and spiral chains when under a scanning electron microscopy (magnification, 6000) with a spore diameter of 0.6 µm ([Figure 2](#marinedrugs-17-00164-f002){ref-type="fig"} and [Figure 3](#marinedrugs-17-00164-f003){ref-type="fig"}; [Table 1](#marinedrugs-17-00164-t001){ref-type="table"} and [Table 2](#marinedrugs-17-00164-t002){ref-type="table"}).

The molecular weight of actinokinase is 38 kDa and the low molecular weight enlightens the high efficiency of fibrin degradation. The enzyme is serine endopeptidase, classified as a hydrolase type of enzyme, which breaks the fibrin and dissolves the clot.

The strain was observed to produce large quantities of double shaped aerial mycelium on yeast extract malt extract agar (ISP 2) when compared to other ISP extract agar ([Table 3](#marinedrugs-17-00164-t003){ref-type="table"}).

Sequence results of 16S rDNA were exported to the database and checked for homologous alignment. Based on the alignment results, strain VITSD8 was found to be *Streptomyces radiopugnans* which showed 99% similarity. The strain name was designated as *Streptomyces radiopugnans* VITSD8. The partial 16S rDNA sequence was deposited in Gen Bank under the accession number KR233811.1. The phylogenetic tree was depicted based on 16S rDNA of the strain *Streptomyces radiopugnans* VITSD8 ([Figure 4](#marinedrugs-17-00164-f004){ref-type="fig"}).

Among eight *Streptomyces* sp. screened for caseinolytic activity, VITSD8 isolate showed promising results representing 12 mm of zone of hydrolysis. *Streptomyces radiopugnans* VITSD8 grown on medium supplemented medium with maltose as the carbon source and peptone as the nitrogen source showed a better activity of 781 U/mL. The strain grown in the medium at pH 7 and temperature 33 °C showed 567 U /mL and 587 U/mL activity ([Figure 5](#marinedrugs-17-00164-f005){ref-type="fig"}).

In anion exchange chromatography using DEAE cellulose, the fibrinolytic activity was eluted in 24 fractions ([Figure 6](#marinedrugs-17-00164-f006){ref-type="fig"}a). The 5th elution sample showed a maximum activity of 884 U/mL. The active fraction was further purified by size exclusion chromatography using a Sephadex G100 column. The maximum fibrinolytic activity of the purified enzyme was found to be 1426 U/mL ([Figure 6](#marinedrugs-17-00164-f006){ref-type="fig"}b). The purification fold of enzyme produced from *Streptomyces radiopugnans* VITSD8 is represented in [Table 4](#marinedrugs-17-00164-t004){ref-type="table"}. The fibrinolytic activity of protease from *S. radiopugnans* VITSD8 was increased by 35-fold after purification, and the final yield was 22.36%.

The enzyme was purified to homogeneity resulting in 22.36-fold purification and 35% activity recovery. From the purification table, the specific activity of marine *Streptomyces radiopugnans* VITSD8 is 3891 U/mg, which is higher than the specific activity of 2563.6 U/mg of terrestrial *Streptomyces* sp. P3 strain isolated from soil \[[@B28-marinedrugs-17-00164]\].

SDS-PAGE analysis presented a single band in the sample corresponding to a molecular weight of 38 kDa ([Figure 7](#marinedrugs-17-00164-f007){ref-type="fig"}).

An electrophoretic analysis of *Streptomyces radiopugnans* VITSD8 was carried out in 12% (*w*/*v*) polyacrylamide slab gel according to the method of Laemmli. Gels were stained with Coomassie Brilliant Blue R-250 and destained with ethanol/glacial acetic acid/distilled water (1:1:8, by vol.). Protein marker sizes in kDa are shown at the right of the lane and purified proteins from *Streptomyces radiopugnans* VITSD8 at left side. Based on the results it was found that the enzyme could lyse both natural clots as well as synthetic clots of fibrinogen, plasmin, and thrombin. A very high variation in clot lysis activity of purified enzyme and positive control (streptokinase) was observed ([Figure 8](#marinedrugs-17-00164-f008){ref-type="fig"}). The fibrin plate method was used to determine the activity of purified fibrinolytic protease against the clot. The clear zone of hydrolysis on a fibrin degradation agar plate of 30 mm indicates the fibrinolytic activity of the enzyme ([Figure 9](#marinedrugs-17-00164-f009){ref-type="fig"}). The release of RBCs was 100% with purified *Streptomyces radiopugnans* VITSD8 fibrinolytic protease at the 20th and 30th min of incubation, while the control clot indicated the release of RBCs at 30 min ([Table 5](#marinedrugs-17-00164-t005){ref-type="table"}).

The HPLC profile represented the retention time at 3.48 min and it showed a single peak, indicating the purity of enzyme ([Figure 10](#marinedrugs-17-00164-f010){ref-type="fig"}). The FTIR profile of the purified fibrinolytic protease showed a characteristic O-H stretch at 3244 cm^−1^, followed by carboxylic acid O-H stretch at 2700 cm^−1^. The peak at 1422 cm^−1^ was attributable to a carbonyl stretching vibrations. In addition, the peak at around 1062 cm^−1^ is attributed to C-C bond stretching. Furthermore, the peak at 993 cm^−1^ was attributed to an aromatic binding and the peak at 617cm^−1^ corresponded to C-Cl stretching ([Figure 11](#marinedrugs-17-00164-f011){ref-type="fig"}).

Some of the previous studies reported in fibrinolytic protease from actinomycetes includes *Streptomyces spheroids* M8 \[[@B15-marinedrugs-17-00164]\] and *Actinomyces thermovulgaris* \[[@B17-marinedrugs-17-00164]\]. The cloning and expression of the thermophilic *Streptomyces* actinokinase gene has also been reported \[[@B29-marinedrugs-17-00164]\]. A purified enzyme from thermophilic *Streptomyces megasporus* SD5 showed a potential fibrinolytic property at 0.11 mg crude enzyme with a specific activity of 4.2 U \[[@B29-marinedrugs-17-00164]\]. Post-electrophoretic reactivity revealed a monomeric form of the enzyme with a molecular weight of 35 kDa. The optimum pH and temperature for production of the enzyme was 8 and 55 °C, respectively. The enzyme was resistant to a broad range of pH ranging from 6 to 9 and temperature ranging from 37 °C to 60 °C. Hence the study also justifies and confirms the characteristics of the fibrinolytic enzyme which mimics actinokinase; further conformational studies will help for a better understanding of its functional properties.

Marine microorganisms have been reported to have fibrinolytic, caseinolytic, and albuminolytic properties \[[@B30-marinedrugs-17-00164]\]. The fibrinolytic proteases, especially actinokinases, are mostly produced from non-pathogenic actinomycetes. It is a neutral enzyme. They have higher specificity towards N-succinyl-Ala-Ala-Pro-Phe-pNA, a substrate of chymotrypsin \[[@B31-marinedrugs-17-00164]\]. Actinobacteria, *Streptomyces rimosus*, has been reported for its maximum fibrinolytic activity of 800 U/mL \[[@B32-marinedrugs-17-00164]\]. A thermophilic actinoprotease produced by *Streptomyces* sp. isolated from soil samples of the Khartoum region of Sudan has been reported to have efficient fibrinolytic activity \[[@B30-marinedrugs-17-00164]\]. Similarly, reports on *Streptomyces rubiginosus* VITPSS1 \[[@B33-marinedrugs-17-00164]\] also stated that fibrinolytic enzymes from marine actinomycetes act faster than the commercially existing enzymes and instigate further to explore more fibrinolytic enzyme producing marine *Streptomyces* sp.

4. Conclusions {#sec4-marinedrugs-17-00164}
==============

This is the first report on fibrinolytic protease producing *Streptomyces radiopugnans* VITSD8 isolated from marine sponges. The results of the study strongly suggest that the protein is a fibrinolytic enzyme. The enzyme degraded the clot by direct fibrinolysis more efficiently than the positive control (streptokinase). This fibrinolytic enzyme was highly active and stable in moderate pH and temperature. It can be further developed as a potential candidate for thrombolytic therapy in clinical trials. A clot-busting enzyme provides new hope for cancer, stroke, and heart patients. Enzymes from natural marine isolates are the important pharmacological substances which can be used for developing new and effective fibrinolytic agents. The outcome of the current research would present a new window of opportunity for the treatment of cardiovascular diseases. Furthermore, the identification and characterization of proteins would lead to the possibility of developing drugs, and thus making a better formulation, to be used for treatment. To our knowledge, this is one among the few studies on fibrinolytic investigation of enzymes in vitro. Hence studies on actinobacteria will lead to identifying and establishing the most fibrinolytic enzymes which will be effective against cardiovascular diseases. In the near future, the strain *Streptomyces radiopugnans* VITSD8 will serve as a potential source for the commercial production of fibrinolytic enzymes.

The authors thank Vellore Institute of Technology for providing 'VIT SEED GRANT' for carrying out this research work. The authors are thankful to Vellore Institute of Technology for the constant encouragement, help and support for extending necessary facilities. They also extended their appreciation to Technology Business Incubator (TBI), VIT, Vellore for the use of HPLC, FTIR facility and DST-FIST cum VIT Funded Scanning Electron Microscope Lab facility.

S.D.C. conceived the original idea, designed the experiments, directed the research and supervised the findings of the work. D.D. performed the experiments and took the lead in writing the manuscript and data curation. J.N.S. verified the analytical methods, M.K.S., interpretation of the results and edited the data. All the authors provided critical feedback & contributed in writing---review and editing.

This research was not funded by any external agency.

The authors declare that they have no conflict of Interest.
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![Scanning electron micrograph representing the spore chain morphology of *Streptomyces radiopugnans* VITSD8.](marinedrugs-17-00164-g003){#marinedrugs-17-00164-f003}
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![(**a**) Elution profile of *Streptomyces radiopugnans* VITSD8 for Ion exchange with Poros-HQ column (**b**) elution profile of *Streptomyces radiopugnans* VITSD8 for a size exclusion chromotography with Sepharose CL-6B column. The enzyme activity was expressed in terms of U/mL.](marinedrugs-17-00164-g006){#marinedrugs-17-00164-f006}

![SDS-PAGE analysis of protein produced from *Streptomyces radiopugnans* VITSD8 (Sample-38 KDa protein).](marinedrugs-17-00164-g007){#marinedrugs-17-00164-f007}

![Blood clot lysis of Purified fibrinolytic protease from *Streptomyces radiopugnans* VITSD8 strain. (A---40%, B---50%, C---60%, D---70%, E---80%, F---90%, G---100%, H---PC (streptokinase), and I- NC (buffer).](marinedrugs-17-00164-g008){#marinedrugs-17-00164-f008}

![Casein plasminogen assay (80% of purified fibrinolytic protease showed 30 mm of clear zone).](marinedrugs-17-00164-g009){#marinedrugs-17-00164-f009}

![HPLC analysis of purified fibrinolytic protease from *Streptomyces radiopugnans* VITSD8 strain. The retention time is 3.48 min.](marinedrugs-17-00164-g010){#marinedrugs-17-00164-f010}

![FTIR profile of purified fibrinolytic protease from *Streptomyces radiopugnans* VITSD8. The frequency of 1062.78 indicates the presence of a strong aliphatic group in the *Streptomyces radiopugnans* VITSD8 protease.](marinedrugs-17-00164-g011){#marinedrugs-17-00164-f011}

marinedrugs-17-00164-t001_Table 1

###### 

Biochemical and physiological properties of *Streptomyces* sp. VITSD8.

  Microscopy                    Corn Steep Liquor         \+
  ------------------------ ---- ------------------------- ----
  Grams Stain              \+   Sodium acetate            \+
  Colony Pigmentation      \-   Sodium citrate            \-
  Melanin Pigmentation     \-   Urea                      \-
  Motility                 \-   Effect of Temperature     
  Soluble Pigment          \-   15 °C                     \-
  Carbon Source            \-   28 °C                     \+
  D-glucose                \+   37 °C                     \+
  D-galactose              \-   45 °C                     \-
  Mannose                  \+   Effect of pH              
  Maltose                  \+   5                         \-
  Lactose                  \+   6                         \-
  Trehalose                \+   7                         \+
  Melibose                 \-   8                         \-
  Amino Acid Utilization        9                         \-
  Cysteine                 \+   NaCl Concentration        
  Arginine                 \+   1%                        \+
  Therionine               \+   2%                        \+
  Alanine                  \+   3%                        \-
  Aspartic acid            \+   5%                        \-
  Glycine                  \+   10%                       \-
  Histidine                \-   Hydrolysis                
  Lysine                   \+   Starch Hydrolysis         \+
  Phenyl alanine           \+   Nitrate Reduction         \-
  Tryptophan               \+   Gelatin Liquefaction      \+
  Methionine               \+   Hemolysis on Blood Agar   \+
  Isoleucine               \-   Esculin Hydrolysis        \-
  Valine                   \-   H~2~S                     \-
  Ornithine                \-   Antibiotic Resistance     
  Asparagine               \-   Streptomycin              S
  Nitrogen Source               Tetracyclin               S
  Peptone                  \+   Bacitracin                R
  Yeast Extract            \+   Kanamycin                 S
  Casein                   \+   Ampicillin                R
  Ammonium Sulphate        \+   Gentamicin                R
  Ammonium Nitrate         \+   Rifampacin                R
  Ammonium Citrate         \+   Vancomycin                S
  Beef Extract             \+   Fluconazole               R

marinedrugs-17-00164-t002_Table 2

###### 

Phenotypic properties separating the strain VITSD8 from related species according to the nonomura key.

  Characteristic Features   *Streptomyces* sp. VITSD8   Utilization of Carbon Sources   
  ------------------------- --------------------------- ------------------------------- ---
  Spore surface             Smooth                      Arabinose                       ₊
  Spore chain morphology    Rectiflexibles              Xylose                          ₋
  Aerial mycelium           Grey                        Inositol                        ₊
  Melanoid pigment          \-                          Mannitol                        ₊
  Reverse side pigment      \-                          Fructose                        ₊
  Soluble pigment           \-                          Rhamnose                        ₊
                                                        Sucrose                         ₊
                                                        Raffinose                       ₊

marinedrugs-17-00164-t003_Table 3

###### 

Cultural characteristics of strain *Streptomyces* sp. VITSD8 on various media.

  Medium                                           Growth      Aerial Mycelium   Substrate Mycelium
  ------------------------------------------------ ----------- ----------------- --------------------
  Tryptone-Yeast Extract Broth (ISP medium 1)      Good        White             Yellow
  Yeast-malt extract (ISP medium 2)                Very good   White             Yellow
  Oatmeal agar (ISP medium 3)                      Good        White             Yellow
  Inorganic salt starch agar (ISP medium 4)        Good        Grey              Grey
  Glycerol-aspargine agar (ISP 5)                  Good        White             Ash
  Peptone yeast extract iron agar (ISP medium 6)   Slow        Grey              Grey
  Tyrosine agar base (ISP medium 7)                Good        Ash               Ash
  Nitrate agar (ISP 8)                             Good        Ash               Ash
  Carbon utilization agar (ISP medium 9)           Good        White             Grey
  Bennett agar                                     Good        Grey              Grey
  Nutrient agar                                    Slow        White             White
  Czapex Dox agar                                  Good        White             White
  *Kenknight's agar*                               Good        White             Grey
  Actinomycete isolation agar                      Very good   White             Grey
  Starch casein agar                               Very good   Grey              Grey

marinedrugs-17-00164-t004_Table 4

###### 

Purification of fibrinolytic protease.

  Fractions                             Total Protein (mg)   Relative Activity (U)   Total Activity (U·mL)   Specific Activity (U·mg^−1^)   Fold Purification   \% Yield
  ------------------------------------- -------------------- ----------------------- ----------------------- ------------------------------ ------------------- ----------
  **Crude enzyme**                      71                   247                     12,350                  174                            1                   100
  **Ammonium sulphate precipitation**   15                   545                     7085                    473                            2.7                 57
  **Dialysis**                          8                    697                     6273                    784                            4.51                51
  **Ion-exchange chromatography**       3                    884                     5304                    1768                           10.16               43
  **Size exclusion chromatography**     1.1                  1427                    4281                    3891                           22.36               35

marinedrugs-17-00164-t005_Table 5

###### 

Percentage of Red blood cells (RBCs) released in partial clot lysis assay.

  Time                       10 min (%)   20 min (%)   30 min (%)
  -------------------------- ------------ ------------ ------------
  **Purified**               91           100          100
  **Partially Purified**     57           78           86
  **Ammonium Precipitate**   18           42           73
  **Streptokinase**          87           94           100
